WNB was established to be a major player in the healthcare sector in Egypt and Middle East, committed to manufacturing and distributing high quality pharmaceutical products, to improve human health and well-being....Message from WNB CEO and Managing Director, Mr Mohamed Ibrahim WNB is a fast-growing international pharmaceutical company that manufactures markets and distributes branded and generics pharmaceutical products.Since its incorporation, WNB strategy has been focused on creating a strong pharmaceutical industry that provides quality medicines to its patients and the communities in which it serves. Mission & Vision And, it is my responsibility to continuously build and form a company that is competitive, resilient and innovative, allowing us to successfully navigate in a complex and constantly changing environment. We invest patiently in our assets while exercising a long term strategy, we improve the quality and the value of our assets and we enhance productivity by partnering with professional management teams, skilful labour and high end technology in order to help us reach our full potential. Meet Management Members In July 2021, For the First time in Egypt and Africa Market, we launching the 1st generic biological product, Exapine. We are beginning to see the results of our efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. I would like to thank everyone who has been directly or indirectly involved in supporting our efforts to make WNB’s name synonymous to trust and quality. Finally, we would like to express our sympathy and concern for all who have been affected by COVID-19. We also wish to reaffirm our respect and gratitude for all of the medical professionals and health care personnel who are working to provide care and support during the pandemic.